These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Detection of patients at risk for sudden heart death by long-term ECG. The role of life-threatening ventricular arrhythmias]. Hombach V; Höpp HW; Osterspey A; Winter U; Deutsch H; Hilger HH Herz; 1984 Feb; 9(1):6-25. PubMed ID: 6200415 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death. Kochs M; Eggeling T; Hombach V Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747 [TBL] [Abstract][Full Text] [Related]
4. Prognosis of ventricular arrhythmias in relation to sudden cardiac death: therapeutic implications. Surawicz B J Am Coll Cardiol; 1987 Aug; 10(2):435-47. PubMed ID: 3298363 [TBL] [Abstract][Full Text] [Related]
5. When is drug therapy warranted to prevent sudden cardiac death? Singh BN Drugs; 1991; 41 Suppl 2():24-46. PubMed ID: 1711967 [TBL] [Abstract][Full Text] [Related]
6. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences]. McKenna WJ; Kleinebenne A Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767 [TBL] [Abstract][Full Text] [Related]
7. Ventricular arrhythmias: control of therapy by Holter monitoring. Horowitz LN Eur Heart J; 1989 Sep; 10 Suppl E():53-60. PubMed ID: 2680503 [TBL] [Abstract][Full Text] [Related]
8. Arrhythmias as predictors of sudden death. Coumel P; Leclercq JF; Leenhardt A Am Heart J; 1987 Oct; 114(4 Pt 2):929-37. PubMed ID: 2889343 [TBL] [Abstract][Full Text] [Related]
9. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?]. Zrenner B; Koller B; Rudolph W Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895 [TBL] [Abstract][Full Text] [Related]
10. Can antiarrhythmic drugs survive survival trials? Pratt CM; Waldo AL; Camm AJ Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220 [TBL] [Abstract][Full Text] [Related]
11. Methodology for clinical trials with antiarrhythmic drugs to prevent cardiac death: US experience. Bigger JT Cardiology; 1987; 74 Suppl 2():40-56. PubMed ID: 3621278 [TBL] [Abstract][Full Text] [Related]
12. [Late potentials, myocardial kinetics and ventricular vulnerability as markers of sudden death after myocardial infarct]. D'Aulerio M; Gronda M; Prando MD; Occhetta E; Makmur J; Rossi L; Rossi P G Ital Cardiol; 1986 Feb; 16(2):114-26. PubMed ID: 3721103 [TBL] [Abstract][Full Text] [Related]
14. Identification of sudden death risk factors in acute and chronic coronary artery disease. Vismara LA; Vera Z; Foerster JM; Amsterdam EA; Mason DT Am J Cardiol; 1977 May; 39(6):821-8. PubMed ID: 871108 [TBL] [Abstract][Full Text] [Related]
15. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists? Stevenson WG; Ridker PM JAMA; 1996 Aug; 276(6):481-5. PubMed ID: 8691557 [TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic testing and follow-up of patients with aborted sudden death. Eldar M; Sauve MJ; Scheinman MM J Am Coll Cardiol; 1987 Aug; 10(2):291-8. PubMed ID: 3598002 [TBL] [Abstract][Full Text] [Related]